Discover pharmacovigilance and how CREATION.co can help you follow good pharmacovigilance practice
What is pharmacovigilance?
Pharmacovigilance is defined as ‘the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem’ (WHO & EMA). Monitoring the safety of medicines in healthcare practice allows both healthcare professionals (HCPs) and the general public to understand the associated risks and benefits. Consider the global race to identify and develop a COVID-19 vaccine. While in this example scenario it was critical to develop a vaccine rapidly, it is paramount that this is balanced with safety and efficacy –this is where pharmacovigilance comes in.
Pharmacovigilance vs. drug safety
Although used interchangeably a slight difference exists between these two terms. Drug safety reactively examines and reports on data collected during clinical trials and in the post-marketing environment to inform regulatory agencies and reimbursement authorities. Pharmacovigilance, on the other hand, proactively considers the environment and identifies signals and trends within large patient populations, providing significant insight into how drugs are performing in the real world. Pharmacovigilance data is a key consideration during regulatory, reimbursement, and commercial discussions.
Understand pharmacovigilance inside and outside of clinical research
Pharmacovigilance analyses conducted in clinical research trials provide data on the safety profile of the drug but, in this setting, pharmacovigilance data is limited due to study restrictions. Typically, at the time of its authorisation, a medicine has been tested in a relatively small number of selected patients for a limited length of time. However, outside of the clinical research setting, the conditions of use change. Continued pharmacovigilance in the real-world is necessary to update the potential risks of drugs.
Realise what good pharmacovigilance practice is
It is essential that the safety of all medicines is monitored throughout their use in healthcare practice through consistent pharmacovigilance strategies that comply with Good Pharmacovigilance Practice (GVP). The European Medicines Agency along with the Pharmacovigilance Risk Assessment Committee (PRAC), the Food and Drug Administration and Health Canada all outline specific expectations for GVP.
How can CREATION.co help?
CREATION.co is highly skilled in industry-leading pharmacovigilance processes. Uncover real-world cases and little-known side effects of your product(s) with our latest advancements in social media analysis and innovative drug safety signal detection methodology. Learn more about how we can help with drug safety monitoring and enhanced pharmacovigilance.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.